Moreover, the expression of SESN2 in SW620 and LoVo cells, derived from the metastatic site of CRC, was significantly lower than that in the HT‐29 and SW480 cells, derived from the primary lesion of CRC (Wei et al. 2015). The gene discussed is SESN2; the disease is colorectal carcinoma.